The 'blood group O problem' in kidney transplantation-time to change?

Nephrology Dialysis Transplantation

Volumn 25, Issue 6, 2010, Pages 1998-2004

  Glander, Petra ^a   Budde, Klemens ^a   Schmidt, Danilo ^a   Fuller, T Florian ^a   Giessing, Markus ^b   Neumayer, Hans Hellmut ^a   Liefeldt, Lutz ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Allocation; Blood group O; Kidney transplantation; Outcome; Waiting time

Indexed keywords

ADULT; ARTICLE; BLOOD GROUP O; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HLA MATCHING; HOSPITAL ADMISSION; HUMAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESOURCE ALLOCATION; RETROSPECTIVE STUDY;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUPING AND CROSSMATCHING; EUROPE; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; WAITING LISTS;

EID: 77952994485     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp779     Document Type: Article

References (14)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730
2. Kimmel PL, Cohen SD, Weisbord SD. Quality of life in patients with end-stage renal disease treated with hemodialysis: survival is not enough! J Nephrol 2008; 21: S54-S58
3. Griva K, Jayasena D, Davenport A et al. Illness and treatment cognitions and health related quality of life in end stage renal disease. Br J Health Psychol 2009; 14: 17-34
4. Opelz G, Döhler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007; 84: 137-143
5. Quiroga I, McShane P, Koo DD et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006; 21: 1689-1696
6. Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002; 74: 1377-1381
7. Eurotransplant International Foundation. http://www.eurotransplant.nl.
8. Schröter K, Lindemann G, Fritsche L. TBase2\a web-based electronic patient record. Fundamenta Informaticae 43. Amsterdam: IOS Press, pp. 343-353
9. Lindemann G, Fritsche LWeb-based patient records\the design of TBase2. In: Köckerling Bruch, Schug-Pa Bouchard (eds). New Aspects of High Technology in Medicine 2000, pp. 409-414
10. BQS-Outcome 2008. http://www.bqs-outcome.de.
11. Eurotransplant International Foundation. Statistics. Annual Report. http://www.eurotransplant.nl/?id=annual-report.
12. Tydén G, Donauer J, Wadström J et al. Implementation of a Protocol for ABO-incompatible kidney transplantation\a three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153-1155
13. de Klerk M, Witvliet MD, Haase-Kromwijk BJ et al. A highly efficient living donor kidney exchange program for both blood type and crossmatch incompatible donor-recipient combinations. Transplantation 2006; 82: 1616-1620
14. Rees MA, Kopke JE, Pelletier RP et al. A nonsimultaneous, extended, altruistic-donor chain. N Engl J Med 2009; 360: 1096-1101